These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20273672)

  • 1. A further investigation of the ability of sarcosine to serve as a labile methyl donor.
    Du VIGNEAUD V; SIMMONDS S; COHN M
    J Biol Chem; 1946 Nov; 166(1):47-52. PubMed ID: 20273672
    [No Abstract]   [Full Text] [Related]  

  • 2. Labile methyl group balances in the human: the role of sarcosine.
    Mudd SH; Ebert MH; Scriver CR
    Metabolism; 1980 Aug; 29(8):707-20. PubMed ID: 6157075
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of sarcosine formation in methionine methyl carbon oxidation in the rat.
    Mitchell AD; Benevenga NJ
    J Nutr; 1976 Dec; 106(12):1702-13. PubMed ID: 993851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
    Tsai G; Lane HY; Yang P; Chong MY; Lange N
    Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe-Dnmts axis.
    Strmiska V; Michalek P; Lackova Z; Guran R; Krizkova S; Vanickova L; Zitka O; Stiborova M; Eckschlager T; Klejdus B; Pacik D; Tvrdikova E; Keil C; Haase H; Adam V; Heger Z
    Mol Oncol; 2019 May; 13(5):1002-1017. PubMed ID: 30628163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models.
    Socała K; Nieoczym D; Rundfeldt C; Wlaź P
    Pharmacol Rep; 2010; 62(2):392-7. PubMed ID: 20508295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monomeric sarcosine oxidase: 1. Flavin reactivity and active site binding determinants.
    Wagner MA; Trickey P; Chen ZW; Mathews FS; Jorns MS
    Biochemistry; 2000 Aug; 39(30):8813-24. PubMed ID: 10913292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of glycine sarcosine N-methyltransferase and sarcosine dimethylglycine N-methyltransferase.
    Nyyssölä A; Reinikainen T; Leisola M
    Appl Environ Microbiol; 2001 May; 67(5):2044-50. PubMed ID: 11319079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the sarcosine molecules of actinomycins.
    Ciferri O; Albertini A; Cassani G
    Biochem J; 1965 Sep; 96(3):853-61. PubMed ID: 4159551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials.
    Lee MY; Lin YR; Tu YS; Tseng YJ; Chan MH; Chen HH
    J Biomed Sci; 2017 Feb; 24(1):18. PubMed ID: 28245819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
    Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
    J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).
    Strzelecki D; Kałużyńska O; Szyburska J; Wysokiński A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible role for sarcosine in the management of schizophrenia.
    Curtis D
    Br J Psychiatry; 2019 Dec; 215(6):697-698. PubMed ID: 31685041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA Receptor-mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role.
    Chen KT; Tsai MH; Wu CH; Jou MJ; Wei IH; Huang CC
    Front Behav Neurosci; 2015; 9():162. PubMed ID: 26150775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a third coenzyme in sarcosine oxidase.
    Willie A; Jorns MS
    Biochemistry; 1995 Dec; 34(51):16703-7. PubMed ID: 8527444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain.
    Long KD; Mastropaolo J; Rosse RB; Manaye KF; Deutsch SI
    Brain Res Bull; 2006 May; 69(6):626-30. PubMed ID: 16716829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
    Grzonka Z; Lammek B; Kasprzykowski F; Gazis D; Schwartz IL
    J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcosine therapy for obsessive compulsive disorder: a prospective, open-label study.
    Wu PL; Tang HS; Lane HY; Tsai CA; Tsai GE
    J Clin Psychopharmacol; 2011 Jun; 31(3):369-74. PubMed ID: 21508860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and properties of recombinant corynebacterial sarcosine oxidase: evidence for posttranslational modification during turnover with sarcosine.
    Chlumsky LJ; Zhang L; Ramsey AJ; Jorns MS
    Biochemistry; 1993 Oct; 32(41):11132-42. PubMed ID: 7692961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.